SleepApneaDisorder/ DEARBORN, MI/ January 28, 2012 /PressRelease/ — Patients suffering from sleep apnea and snoring can now seek treatment from Dr. Bruce Luria, Dearborn dentist. Dr. Bruce Luria is currently a member of the Academy of Dental Sleep Medicine and is pleased to share his expertise with other members of Luria & Birnholtz Family Dentistry and his patients to improve their quality of life.

The American Academy of Dental Sleep Medicine (AADSM) is dedicated to the treatment of sleep-related breathing disorders through use of oral appliance therapy. As part of the AADSM’s stated mission, Dr. Bruce Luria, Dearborn, MI dentist, works with his patients to create a positive public awareness of sleep disorders such as snoring and obstructive sleep apnea in Dearborn.  Read the rest of this entry

Home sleep testing devices have become popular among medical providers to  determine whether or not patients may have obstructive sleep apnea.  Left  untreated, sleep apnea can account for higher risks of accidents, obesity, heart  disease, diabetes, and even colon cancer.

Medical professionals upload raw data  off the machine through the pm-Assist?  service that is scored by Registered Polysomnographic Technicians (RPSGT),  interpreted by Board Certified Sleep Physicians, and in as little as 24 hours  receive a diagnostic report.

“The growth of our pm-Assist program parallels the growth of home sleep  testing in the industry,” commented Dr. Benjamin Gerson, Chief Medical Director  of University Services, the parent  company of pm-Assist. Read the rest of this entry

As the number of patients diagnosed with sleep apnea is increasing the costs related to the health insurance is also increasing exponentially. This skyrocketing of the insurer’s sleep apnea related costs has now compelled the insurance companies to change their health coverage policies for the disorder.

A sleep apnea diagnosis usually requires patients undergo tests overnight in a sleep lab; some patients spend two nights in the lab to separately test for sleep apnea and to try a continuous positive airway pressure (CPAP) machine. Insurers often spend $1,900 for one overnight stay.

As a result of this increased spending, some experts are concerned that overnight tests to diagnose apnea are over-prescribed. Medicare payments for sleep testing increased from $62 million in 2001 to $235 million in 2009.

This contrasts effective home sleep tests that cost less than a fifth of the lab version. Although Medicare began paying for home sleep tests in 2008, the tests have had only modest growth. Read the rest of this entry

Verizon Wireless and NovaSom, Inc., the leader in obstructive sleep apnea (OSA) home testing, will be showcasing the NovaSom’s AccuSom  Home Sleep Test at 2012 International Consumer Electronics Show (CES), [the Verizon booth ,Las Vegas Convention Center, South Hall, Booth #30259].

The AccuSom Home Sleep Test is used in the diagnosis of obstructive sleep apnea(OSA), one of the most serious and under-diagnosed medical conditions in the United States, affecting nearly 18 million Americans.  AccuSom is the only FDA-cleared wireless home sleep test on the market, utilizing Verizon’s network to wirelessly collect and transfer sleep data from the patient’s home to a proprietary cloud-based sleep apnea management platform for physician interpretation and diagnosis. Read the rest of this entry

UT Arlington bioengineering researchers have designed an innovative, ultrasonic sensor system that can accurately detect whether a person suffers from sleep apnea without the inconvenience or cost associated with an overnight stay in a sleep center.

The University of Texas at Arlington has applied for a provisional patent for the concept and technology. Researchers are currently identifying private partners to market the device. UT Arlington has formed an alliance with Sleep Consultants Inc. in Fort Worth to conduct studies related to the research.

Sleep apnea affects an estimated 15 percent of adults nationwide. The chronic interruption of breathing can lead to hypertension, heart failure and even some brain injuries. The new detection system promises a speedier path to diagnosis and eventual relief, said Khosrow Behbehani, professor and chair of the UT Arlington Department of Bioengineering. Read the rest of this entry

If you are suffering from the deadly sleep disorder called the obstructive sleep apnea (OSA) then you’re not breathing properly while you sleep because your airflow is blocked repeatedly throughout the night.

Almost one in four men and one in ten women suffer from sleep apnea. There are three different types of sleep apnea but obstructive sleep apnea (OSA) is the most common. And it goes hand-in-hand with type 2 diabetes.

Among all of the sleep disorders, OSA has the strongest association with type 2 diabetes. That’s even taking into account other risk factors, such as weight, sex and age.

The main risk factor for OSA is obesity. Excess weight deposits extra fat around the thorax, reducing chest compliance and functional capacity, while increasing oxygen demand. Read the rest of this entry

Lee A. Surkin, MD is the first medical practice in the state of North Carolina to offer Provent Sleep Apnea Therapy, an innovative, non-invasive treatment for obstructive sleep apnea (OSA) to patients in Greenville and throughout North Carolina. Cleared by the US FDA in 2008, Provent Therapy is a simple and effective new treatment option for obstructive sleep apnea. Provent Therapy utilizes the patient’s own breathing to provide clinically proven results in the treatment of OSA.

CPAP (continuous positive airway pressure) is currently the gold standard for treatment of OSA and is extremely effective at treating OSA when worn as directed. However, up to half of all patients are not compliant with CPAP therapy due to the cumbersome nature of the treatment. Provent Therapy was developed to help patients who cannot tolerate CPAP therapy and may benefit from the small non-invasive and effective technology Provent Therapy provides. Read the rest of this entry

Reportlinker.com announces that a new market research report is available in its catalogue:

United States Anesthesia and Respiratory Devices Market Outlook to 2017 – Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

The report provides key market data on the United States Anesthesia and Respiratory Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within eight market categories – Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables, Respiratory Measurement Devices and Sleep Apnea Diagnostic Systems. Read the rest of this entry

For patients with severe obstructive sleep apnea, three months of continuous positive airway pressure (CPAP) therapy is associated with reduced blood pressure, and partial reversal of metabolic abnormalities, according to a study published in the Dec. 15 issue of the New England Journal of Medicine.

Surendra K. Sharma, M.D., Ph.D., from the All India Institute of Medical Sciences in New Delhi, and colleagues investigated the effects of CPAP treatment on metabolic syndrome in 86 patients with obstructive sleep apnea syndrome. Patients were assigned to real or sham CPAP for three months, followed by a washout period of one month, and then a crossover to the other intervention for three months. Anthropometric variables, blood pressure, fasting blood glucose levels and lipid profile, insulin resistance, glycated hemoglobin levels, carotid intima-media thickness, and visceral fat were measured before and after each intervention. Read the rest of this entry

The Motor Carrier Safety Advisory Committee and  the Medical Review Board of the FMCSA held a joint  public meeting in Alexandria, VA, to discuss guidance for medical examiners  to identify commercial drivers with a high pre-test probability of having  Obstructive Sleep Apnea, define conditional certification, and what constitutes  immediate disqualification. “These recommendations are a step in the right  direction,” commented Richard Thiel, Director of Making Sleep Work For You?, a  nationwide sleep disorder program, “both entities recognize how OSA is an issue  in the industry, and are taking steps to not only address it, but also give  clear guidelines to all stakeholders involved.”

Subcommittees of each group working together will meet in January to draft  more detailed recommendations to the FMCSA, and another joint meeting of these  entities will take place in February 2012 to finalize the detailed  recommendations. A public comment period will also be available before the FMCSA  issues these recommendations as final guidance. Read the rest of this entry

In a shrewd execution of its business plan and growth strategy, Craig Sizer,  Co-founder and Chairman, with Keith Houlihan, Co-founder and President of Sanomedics International Holdings  Inc. announced the signing of a letter of  intent to acquire a strategically targeted durable medical equipment (DME)  provider with a platform in sleep apnea treatment services.  The targeted  acquisition is accredited by the “Healthcare Quality Association.” The operation  with approximately $6 million in revenues and over $1 million in (EBITDA)  earnings before interest, taxes, depreciation and amortization is expected to  close in early 2012 upon the completion of due diligence and Sanomedics board  approval.

“The acquisition of a sleep treatment service based operations is an  important step in the growth of Sanomedics,  as well as for the distribution and sales expansion of our ThermoMedics line of non-contact clinical thermometers,”  said Craig Sizer Chairman and Co-founder. Read the rest of this entry

Gone are the days of an unaffordable oral appliance used to treat the deadly disorder Sleep Apnea.  With over 18 million Americans affected by Obstructive  Sleep Apnea (OSA), it was only a matter of time the market demanded an  affordable and effective oral appliance to treat sleep apnea.  Respire Medical, a Brooklyn based oral  appliance company teamed up with Gergen’s  Orthodontic Lab to provide a significantly less expensive solution to the  worlds Sleep Apnea sufferers.  Dentists can now attend a dental continuing education course  offered by Sleep Group Solutions to learn more the Respire Blue Series and offer an  affordable option.

“As we continue to grow we would like to welcome all of our new clients and  wish them much success in their treatment of OSA with our Respire devices.”   says David Walton, co-creator of the Respire Blue Series.  “Now that we have  been added to the list of Medicare approved devices by the PDAC board, our  Respire Blue Series device is available to more people.”  With a price point  that’s affordable, Respire Medical offers the best value for money across the  market, hands down. Read the rest of this entry

The Snoring Center, the nation’s leading provider of minimally invasive, office-based treatment for snoring and sleep apnea, including the Pillar Procedure from Medtronic, announced the addition of a Gulf Coast center to open January 6.

“We continue to find innovative professionals like Dr. Weiss to join our team and help achieve our mission to change the way people think about snoring and other sleep-related disorders”

Dr. Ray Weiss, a Board Certified Otolaryngologist, will serve as Medical Director of the Snoring Center’s Ocean Spring location, serving patients along the Gulf Coast, from Mobile, Alabama to New Orleans, Louisiana.

“I am proud to be able to bring relief to patients with the support of The Snoring Center,” said Dr. Weiss. “We are working to improve quality  of life for patients all over the world. Continuing to expand The Snoring Center team into new markets allows ease of access for the men and women seeking minimally invasive, office-based snoring and sleep apnea treatment, and I am glad to be a part of it.” Read the rest of this entry

Sleep apnea is a dangerous problem that can lead to heart attacks, strokes, excessive daytime sleepiness, short-term memory loss and increases in motor vehicle accidents. It is essential to diagnose and treat sleep apnea. One study showed a 36% decrease in 8 year survival comparing treated and untreated sleep apnea.

A problem frequently experienced is that the cost of health, life and disability insurance policies can increase exponentially following diagnosis of sleep apnea. This is problematic for owners of small businesses and wealthy individuals who utilize life insurance to protect their estates. Read the rest of this entry

Henry Schein Inc., the largest provider of health care products and services to office-based practitioners, today announced the launch of its Sleep Complete™ program, a new integrated comprehensive solution that provides all of the information and products necessary for the successful implementation of dental sleep medicine into the dental practice. A key component of this package will be Itamar-Medical’s WatchPAT home test device for the diagnosis of obstructive sleep apnea.The Sleep Complete package will be offered to dentists through a bundled financing package which should significantly lower the financial barrier to entry that often faces dentists interested in incorporating sleep medicine into their practice. Read the rest of this entry